Cafepharma Today

April 24 2024 - About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows
About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows
Biogen cost cuts drive profit beat, Alzheimer's drug sales jump
BMS Initiates First Round of Layoffs in New Jersey
Enter Xaira, with $1bn for its AI in drug discovery platform
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson's Remicade meets key goal in pediatric ulcerative colitis study
Yahoo/AP
Monday, May 9, 2011 - 6:48pm
tags:
JNJ, ulcerative colitis, Remicade
Drug Makers Replace Reps With Digital Tools
WSJ Online
Monday, May 9, 2011 - 6:45pm
tags:
drug reps, e-detailing
GTx’s income falls, reports $2.6M loss in Q1
Bizjournals.com
Monday, May 9, 2011 - 5:02pm
tags:
GTx, earnings
Orexigen Therapeutics posts smaller 1Q loss
Yahoo/AP
Monday, May 9, 2011 - 4:59pm
tags:
Orexigen, earnings, Contrave
Isis Pharma Loss Widens
Yahoo/Zacks.com
Monday, May 9, 2011 - 4:58pm
tags:
Isis Pharmaceuticals, earnings
Lower Generic Sales Affect Par Revs
Yahoo/Zacks.com
Monday, May 9, 2011 - 4:57pm
tags:
Par Pharmaceutical, earnings
Novavax Q1 revenues up
Pharmaceutical Business Review
Monday, May 9, 2011 - 11:09am
tags:
Novavax, earnings
Valeant Posts 1Q Profit As Revenue Doubles; Boosts EPS View
WSJ Online
Monday, May 9, 2011 - 11:08am
tags:
earnings, Valeant Pharmaceuticals
Affymetrix Gene-Expression Reagents Win FDA Clearance; Shares Up
WSJ Online
Monday, May 9, 2011 - 11:07am
tags:
Affymetrix, gene expression reagent, FDA
J&J Files New Concerta Lawsuit Against Impax Labs
Drug Discovery & Development
Monday, May 9, 2011 - 11:06am
tags:
JNJ, Concerta, Impax
Sanofi looks to slow down on dealmaking
Fierce Pharma
Monday, May 9, 2011 - 10:57am
tags:
Sanofi, M&A, Genzyme
Mankind Earnings: Looking for a Rebound
Seeking Alpha
Monday, May 9, 2011 - 10:56am
tags:
earnings, MannKind
3 Late-Stage Leukemia Company Previews for ASCO 2011
Seeking Alpha
Monday, May 9, 2011 - 10:31am
tags:
ASCO, leukemia, Celgene, Cyclacel, Sunesis, Supergen, Eisai
Buy Vertex Call Options as Drugmaker May Be Bought, Goldman Says
Bloomberg
Monday, May 9, 2011 - 9:40am
tags:
Vertex Pharmaceuticals, M&A
Pfizer’s Pneumonia Vaccine Found Effective in Ages 50 and Older
Bloomberg
Monday, May 9, 2011 - 9:39am
tags:
Pfizer, pneumonia, vaccines, Prevnar 13
Crohn's patients respond to J&J's Stelara in study
Reuters
Monday, May 9, 2011 - 9:22am
tags:
JNJ, Stelara, Crohn's Disease
Servier Denies Concealing Risk Of Diabetes Drug
Pharmalot
Monday, May 9, 2011 - 9:21am
tags:
diabetes, Servier, Mediator
Vivus Still Looking for Ways to Push Diet Drug Forward
Seeking Alpha
Monday, May 9, 2011 - 9:19am
tags:
Vivus, obesity, Qnexa
Sequenom Announces a Launch Date for Its Non-Invasive Down Syndrome Test
Seeking Alpha
Monday, May 9, 2011 - 9:19am
tags:
Downs Syndrome, Sequenom
[video]Allegan's Plumped-Up Outlook
CNBC
Monday, May 9, 2011 - 9:16am
tags:
David Pyott, Allergan, guidance

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers
Drug Channels
The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels

Latest Jobs

Area Manager-Specialty West
Fields, OR, 97710
CSL Behring
Specialty Account Manager - Baltimore
BALTIMORE, MD, 21276
CSI Pharmacy
Area Manager-Specialty North Central
Fields, OR, 97710
CSL Behring
Account Executive - Hospice
Kansas City, MO, 64117
Agape Care Group
Account Executive - Hospice
Bates City, MO, 64011
Agape Care Group
Account Executive - Hospice
Kansas City, MO, 64171
Agape Care Group
Account Executive - Hospice
East Lynne, MO, 64743
Agape Care Group
Account Executive - Hospice
Mosby, MO, 64073
Agape Care Group
Account Executive - Hospice
Excelsior Springs, MO, 64024
Agape Care Group
Account Executive - Hospice
Warrensburg, MO, 64093
Agape Care Group
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information